X4 Pharmaceuticals (XFOR) Goodwill & Intangibles (2019 - 2025)

X4 Pharmaceuticals has reported Goodwill & Intangibles for 7 years, with the latest figure at $26.7 million in Q4 2025.

• For the quarter ending Q4 2025, Goodwill & Intangibles fell 2.56% year-over-year to $26.7 million; the trailing twelve-month figure through Dec 2025 stood at $26.7 million (down 2.56% YoY), and the FY2025 full-year result was $26.7 million, down 2.56% from the prior year.
• Goodwill & Intangibles for Q4 2025 stood at $26.7 million, roughly flat from $26.8 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $27.8 million in Q2 2024, with the low at $17.4 million in Q4 2021.
• Historically, Goodwill & Intangibles has averaged $22.3 million across 5 years, with a median of $22.0 million in 2021.
• Annual changes were most pronounced in 2021 — Goodwill & Intangibles slumped 36.0% — and 2024, when it surged 59.94%.
• X4 Pharmaceuticals' Goodwill & Intangibles stood at $17.4 million in 2021, then changed by 0.0% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then surged by 57.63% to $27.4 million in 2024, then dropped by 2.56% to $26.7 million in 2025.
• The last three Goodwill & Intangibles figures came in at $26.7 million (Q4 2025), $26.8 million (Q3 2025), and $27.0 million (Q2 2025), per Business Quant data.